Steven Waggoner
Papers
4
Total Citations
216
H-Index
4
About
Steven Waggoner is a clinical researcher whose work sits at the intersection of gynecologic oncology and advanced radiation therapy, with a particular focus on developing effective treatment strategies for recurrent and metastatic gynecologic cancers. His most significant contributions center on the application of stereotactic body radiosurgery (SBRT) and robotic radiosurgery techniques — including CyberKnife technology — to some of the most challenging cases in women's oncology, where prior surgeries, chemotherapy, and radiation have exhausted conventional options. Waggoner's landmark phase II clinical trial examining robotic SBRT for metastatic gynecologic malignancies has accumulated over 100 citations, establishing foundational evidence for the safety and efficacy of ablative radiosurgery in this patient population. His earlier investigations into pelvic relapse management and vulvar carcinoma treatment after prior radiation further demonstrated the potential of these precision techniques where therapeutic alternatives were severely limited. His subsequent phase I trial combining carboplatin and gemcitabine chemotherapy with stereotactic ablative radiotherapy explored a promising synergistic approach to palliative care. Collectively, Waggoner's research has helped reshape the clinical conversation around recurrent gynecologic cancer management, offering meaningful hope to patients previously considered beyond effective treatment reach.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4